Author:
Cimo Adriana,Stergiopoulos Erene,Cheng Chiachen,Bonato Sarah,Dewa Carolyn S
Abstract
Abstract
Background
The prevalence of type II diabetes among individuals suffering from schizophrenia or schizoaffective disorders is more than double that of the general population. By 2005, North American professional medical associations of Psychiatry, Diabetes, and Endocrinology responded by recommending continuous metabolic monitoring for this population to control complications from obesity and diabetes. However, these recommendations do not identify the types of effective treatment for people with schizophrenia who have type II diabetes. To fill this gap, this systematic evidence review identifies effective lifestyle interventions that enhance quality care in individuals who are suffering from type II diabetes and schizophrenia or other schizoaffective disorders.
Methods
A systematic search from Medline, CINAHL, PsycINFO, and ISI Web of Science was conducted. Of the 1810 unique papers that were retrieved, four met the inclusion/exclusion criteria and were analyzed.
Results
The results indicate that diabetes education is effective when it incorporates diet and exercise components, while using a design that addresses challenges such as cognition, motivation, and weight gain that may result from antipsychotics.
Conclusions
This paper begins to point to effective interventions that will improve type II diabetes management for people with schizophrenia or other schizoaffective disorders.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference42 articles.
1. World Health Organization: Diabetes Fact sheet N°312. [http://www.who.int/mediacentre/factsheets/fs312/en/]
2. World Health Organization: 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. [http://www.who.int/nmh/Actionplan-PC-NCD-2008.pdf]
3. Nelms M, Sucher KP, Lacey K, Long Roth S: Nutrition Therapy and Pathophysiology. 2010, Belmont, CA: Wadsworth Cengage Learning, 2
4. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004, 27: 596-601.
5. Heald A: Physical health in schizophrenia: a challenge for antipsychotic therapy. Eur Psychiatry. 2010, 25: S6-S11.
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献